Eris Lifesciences Limited (BOM:540596)
India · Delayed Price · Currency is INR 1,305.40
-5.60 (-0.43%)
At close: Sep 16, 2026
Eris Lifesciences Market Cap
Eris Lifesciences has a market cap or net worth of 180.58 billion as of September 16, 2026. Its market cap has decreased by -20.80% in one year.
Market Cap
180.58B
Enterprise Value
203.42B
Revenue
32.12B
Ranking
n/a
PE Ratio
28.04
Stock Price
1,305.40
ChartMarket Cap Chart
Since June 29, 2017, Eris Lifesciences's market cap has increased from 82.71B to 180.58B, an increase of 118.34%. That is a compound annual growth rate of 8.84%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2026 | 180.58B | -11.95% |
| Dec 31, 2025 | 205.09B | 9.67% |
| Dec 31, 2024 | 187.00B | 51.07% |
| Dec 29, 2023 | 123.79B | 40.63% |
| Dec 30, 2022 | 88.02B | -14.80% |
| Dec 31, 2021 | 103.31B | 31.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Abbott India | 543.69B |
| GlaxoSmithKline Pharmaceuticals | 480.64B |
| J. B. Chemicals & Pharmaceuticals | 387.31B |
| Granules India | 225.41B |
| Caplin Point Laboratories | 209.39B |
| AstraZeneca Pharma India | 169.63B |
| Jubilant Pharmova | 162.36B |
| Viyash Scientific | 112.28B |